Outset Medical, Inc.

Outset Medical, Inc. is a medical technology company that develops hemodialysis solutions to treat kidney failure, including acute kidney injury and end-stage renal disease. Its primary offering is the Tablo Hemodialysis System, an enterprise platform that integrates water purification and on-demand dialysate production into a compact mobile console. The company also provides the Tablo Cartridge, a single-use pre-strung consumable designed for treatment setup, as well as the TabloCart accessory. Through its Tablo Data Ecosystem, which encompasses TabloHub, MyTablo, and TabloDash, Outset Medical delivers cloud-based monitoring, patient analytics, and clinical recordkeeping. The system serves patients and healthcare providers across hospitals, clinics, and home settings.

The company focuses on acute care facilities, post-acute providers including skilled nursing facilities and long-term acute care hospitals, and home dialysis users. Outset Medical maintains experience working with nearly 1,000 acute-care facilities across the United States. Its principal executive offices are located in San Jose, California.

Summary of the business section of Outset Medical's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had 310 full-time employees, with 58% in our field sales and service teams and 42% in the rest of the company.”